Health Catalyst, Inc. HCAT
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -0.38% | -5.25% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.38% | -5.25% | |||
| Cost of Revenue | 0.24% | -0.86% | |||
| Gross Profit | -0.98% | -9.19% | |||
| SG&A Expenses | -9.93% | 4.46% | |||
| Depreciation & Amortization | -9.38% | -5.95% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.19% | -0.49% | |||
| Operating Income | 44.15% | -110.68% | |||
| Income Before Tax | 63.64% | -22.03% | |||
| Income Tax Expenses | -23.91% | 9.23% | |||
| Earnings from Continuing Operations | 63.49% | -21.97% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 63.49% | -21.97% | |||
| EBIT | 44.15% | -110.68% | |||
| EBITDA | 114.78% | -70.27% | |||
| EPS Basic | 64.16% | -19.29% | |||
| Normalized Basic EPS | 32.23% | -36.99% | |||
| EPS Diluted | 64.16% | -19.29% | |||
| Normalized Diluted EPS | 32.23% | -36.99% | |||
| Average Basic Shares Outstanding | 1.88% | 2.25% | |||
| Average Diluted Shares Outstanding | 1.88% | 2.25% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||